An observational study published in JAMA Oncology looks at GLP-1 receptor agonists and cancer risk in adults with obesity. Prof Paul … read more| Science Media Centre
A new survey from AlynMD reveals shifting attitudes toward weight loss medications like Ozempic and which generation is most on board.| Athletech News